Richard I Eisenstadt - Net Worth and Insider Trading
Richard I Eisenstadt Net Worth
The estimated net worth of Richard I Eisenstadt is at least $215,005 dollars as of 2024-12-26. Richard I Eisenstadt is the CFO of Altimmune Inc and owns about 22,010 shares of Altimmune Inc (ALT) stock worth over $166,176. Richard I Eisenstadt is also the CFO of Neos Therapeutics Inc and owns about 42,460 shares of Neos Therapeutics Inc (NEOS) stock worth over $48,829. Details can be seen in Richard I Eisenstadt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard I Eisenstadt has not made any transactions after 2023-03-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard I Eisenstadt
Richard I Eisenstadt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard I Eisenstadt owns 4 companies in total, including Neos Therapeutics Inc (NEOS) , Ocera Therapeutics Inc (OCRX) , and Altimmune Inc (ALT) among others .
Click here to see the complete history of Richard I Eisenstadt’s form 4 insider trades.
Insider Ownership Summary of Richard I Eisenstadt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NEOS | Neos Therapeutics Inc | 2020-03-02 | Chief Financial Officer |
| OCRX | Ocera Therapeutics Inc | 2012-08-07 | VP & Finance & CFO |
| ALT | Altimmune Inc | 2023-03-24 | Chief Financial Officer |
 | | 2021-03-31 | Chief Financial Officer |
Richard I Eisenstadt Latest Holdings Summary
Richard I Eisenstadt currently owns a total of 2 stocks. Among these stocks, Richard I Eisenstadt owns 22,010 shares of Altimmune Inc (ALT) as of March 24, 2023, with a value of $166,176 and a weighting of 77.29%. Richard I Eisenstadt also owns 42,460 shares of Neos Therapeutics Inc (NEOS) as of December 12, 2018, with a value of $48,829 and a weighting of 22.71%.
Latest Holdings of Richard I Eisenstadt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALT | Altimmune Inc | 2023-03-24 | 22,010 | 7.55 | 166,176 |
| NEOS | Neos Therapeutics Inc | 2018-12-12 | 42,460 | 1.15 | 48,829 |
Holding Weightings of Richard I Eisenstadt
Richard I Eisenstadt Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard I Eisenstadt has made a total of 1 transactions in Altimmune Inc (ALT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Altimmune Inc is the acquisition of 10,000 shares on March 24, 2023, which cost Richard I Eisenstadt around $43,100.
According to the SEC Form 4 filings, Richard I Eisenstadt has made a total of 0 transactions in Neos Therapeutics Inc (NEOS) over the past 5 years. The most-recent trade in Neos Therapeutics Inc is the acquisition of 5,000 shares on December 12, 2018, which cost Richard I Eisenstadt around $10,800.
Insider Trading History of Richard I Eisenstadt
- 1
Richard I Eisenstadt Trading Performance
GuruFocus tracks the stock performance after each of Richard I Eisenstadt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard I Eisenstadt is 1.9%. GuruFocus also compares Richard I Eisenstadt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard I Eisenstadt within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard I Eisenstadt's insider trading performs compared to the benchmark.
Performance of Richard I Eisenstadt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.82 | | | | | |
| Relative Return to S&P 500(%) | 16.24 | | | | | |
Richard I Eisenstadt Ownership Network
Richard I Eisenstadt Owned Company Details
What does Neos Therapeutics Inc do?
Who are the key executives at Neos Therapeutics Inc?
Richard I Eisenstadt is the Chief Financial Officer of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include director & Chief Executive Officer Gerald W. Mclaughlin , SVP & General Counsel John M Limongelli , and Chief Commercial Officer Thomas P Mcdonnell .
Neos Therapeutics Inc (NEOS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neos Therapeutics Inc Insider Transactions
Richard I Eisenstadt Mailing Address
Above is the net worth, insider trading, and ownership report for Richard I Eisenstadt. You might contact Richard I Eisenstadt via mailing address: 4819 Emperor Boulevard, Suite 400, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
